Dopamine, immunity, and disease
B Channer, SM Matt, EA Nickoloff-Bybel, V Pappa… - Pharmacological …, 2023 - Elsevier
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function,
regulating many processes including reward, movement, and cognition. Dopamine also …
regulating many processes including reward, movement, and cognition. Dopamine also …
Inflammatory bowel disease treatments and predictive biomarkers of therapeutic response
Inflammatory bowel disease (IBD) is a chronic immune-mediated inflammation of the
gastrointestinal tract with a highly heterogeneous presentation. It has a relapsing and …
gastrointestinal tract with a highly heterogeneous presentation. It has a relapsing and …
Genetic drug target validation using Mendelian randomisation
AF Schmidt, C Finan, M Gordillo-Marañón… - Nature …, 2020 - nature.com
Mendelian randomisation (MR) analysis is an important tool to elucidate the causal
relevance of environmental and biological risk factors for disease. However, causal …
relevance of environmental and biological risk factors for disease. However, causal …
MSCs and inflammatory cells crosstalk in regenerative medicine: concerted actions for optimized resolution driven by energy metabolism
V Planat-Benard, A Varin, L Casteilla - Frontiers in immunology, 2021 - frontiersin.org
Mesenchymal stromal cells (MSCs) are currently widely used in cell based therapy
regarding to their remarkable efficacy in controlling the inflammatory status in patients …
regarding to their remarkable efficacy in controlling the inflammatory status in patients …
Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems
H Hadji, K Bouchemal - Advanced Drug Delivery Reviews, 2022 - Elsevier
The complex pathogenesis of inflammatory bowel disease (IBD) explains the several
hurdles for finding an efficient approach to cure it. Nowadays, therapeutic protocols aim to …
hurdles for finding an efficient approach to cure it. Nowadays, therapeutic protocols aim to …
Psoriasis and gut microbiome—current state of art
K Polak, B Bergler-Czop, M Szczepanek… - International journal of …, 2021 - mdpi.com
Psoriasis is a chronic, immune-mediated inflammatory disease that affects around 125
million people worldwide. Several studies concerning the gut microbiota composition and its …
million people worldwide. Several studies concerning the gut microbiota composition and its …
Exploring the pipeline of novel therapies for inflammatory bowel disease; state of the art review
Crohn's disease (CD) and ulcerative colitis (UC), known as inflammatory bowel diseases
(IBD), are characterized by chronic inflammation of the gastrointestinal tract. Over the last …
(IBD), are characterized by chronic inflammation of the gastrointestinal tract. Over the last …
Monoclonal antibodies: past, present and future
J Posner, P Barrington, T Brier… - Concepts and Principles …, 2019 - Springer
Monoclonal antibodies (mAbs) are immunoglobulins designed to target a specific epitope on
an antigen. Immunoglobulins of identical amino-acid sequence were originally produced by …
an antigen. Immunoglobulins of identical amino-acid sequence were originally produced by …
Emerging treatment options in inflammatory bowel disease: Janus kinases, stem cells, and more
B Misselwitz, P Juillerat, MC Sulz, B Siegmund… - Digestion, 2020 - karger.com
Background: Treatment of inflammatory bowel diseases (IBD) has tremendously improved
during the last 20 years; however, a substantial fraction of patients does not respond to …
during the last 20 years; however, a substantial fraction of patients does not respond to …
Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease
RR Rodríguez, JJ Johnson - Pharmacology & Therapeutics, 2023 - Elsevier
Abstract Inflammatory Bowel Disease (IBD) are autoimmune diseases characterized by
chronic intestinal inflammation. Considered a western disease, IBD incidence in newly …
chronic intestinal inflammation. Considered a western disease, IBD incidence in newly …